187 related articles for article (PubMed ID: 10543762)
1. Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents.
Matsumura SO; Louie L; Louie M; Simor AE
Antimicrob Agents Chemother; 1999 Nov; 43(11):2776-9. PubMed ID: 10543762
[TBL] [Abstract][Full Text] [Related]
2. Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations.
Aeschlimann JR; Zervos MJ; Rybak MJ
Antimicrob Agents Chemother; 1998 Oct; 42(10):2710-7. PubMed ID: 9756782
[TBL] [Abstract][Full Text] [Related]
3. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
Linden PK; Pasculle AW; McDevitt D; Kramer DJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():145-51. PubMed ID: 9511079
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium.
Bonilla HF; Perri MB; Kauffman CA; Zervos MJ
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):127-31. PubMed ID: 8902408
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci.
Eliopoulos GM; Wennersten CB
Antimicrob Agents Chemother; 2002 May; 46(5):1319-24. PubMed ID: 11959562
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group.
Moellering RC; Linden PK; Reinhardt J; Blumberg EA; Bompart F; Talbot GH
J Antimicrob Chemother; 1999 Aug; 44(2):251-61. PubMed ID: 10473233
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
8. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
Kang SL; Rybak MJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
[TBL] [Abstract][Full Text] [Related]
9. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW
Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
[TBL] [Abstract][Full Text] [Related]
10. Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium.
Lorian V; Fernandes F
J Antimicrob Chemother; 1997 May; 39 Suppl A():63-6. PubMed ID: 9511065
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activities of quinupristin/dalfopristin in combination with vancomycin and gatifloxacin against Staphylococcus aureus and Enterococcus faecium clinical isolates].
Gülden E; Ermertcan S
Mikrobiyol Bul; 2009 Jan; 43(1):53-60. PubMed ID: 19334380
[TBL] [Abstract][Full Text] [Related]
12. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases.
Dever LL; Smith SM; Dejesus D; Masurekar M; Patel D; Kaminski ZC; Johanson WG
Microb Drug Resist; 1996; 2(4):407-13. PubMed ID: 9158811
[TBL] [Abstract][Full Text] [Related]
13. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
Bozdogan B; Leclercq R
Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
[TBL] [Abstract][Full Text] [Related]
14. Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium.
Lorian V; Fernandes F
Drugs Exp Clin Res; 1998; 24(2):73-6. PubMed ID: 9675547
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium.
Hill RL; Smith CT; Seyed-Akhavani M; Casewell MW
J Antimicrob Chemother; 1997 May; 39 Suppl A():23-8. PubMed ID: 9511058
[TBL] [Abstract][Full Text] [Related]
16. [Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500)].
Betriu C; Valverde JF; Culebras E; Gómez M; Sánchez A; Palau ML; Picazo JJ
Enferm Infecc Microbiol Clin; 1999; 17(7):335-9. PubMed ID: 10535185
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci.
Messick CR; Pendland SL
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):203-5. PubMed ID: 9401814
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium.
Ristow TA; Noskin GA; Warren JR; Peterson LR
Microb Drug Resist; 1995; 1(4):335-9. PubMed ID: 9158806
[TBL] [Abstract][Full Text] [Related]
19. Quinupristin/dalfopristin: a therapeutic review.
Allington DR; Rivey MP
Clin Ther; 2001 Jan; 23(1):24-44. PubMed ID: 11219478
[TBL] [Abstract][Full Text] [Related]
20. Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China.
Wang S; Guo Y; Lv J; Qi X; Li D; Chen Z; Zhang X; Wang L; Yu F
BMC Microbiol; 2016 Oct; 16(1):246. PubMed ID: 27769188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]